Raising HDL beats further LDL loweringBut controversial add-on drug trial measured plaque buildup, not clinical endpoints New lipid guidelines focus on LDL targets Everolimus-eluting stent goes to head of class Long-term BP control achieved with renal nerve ablation Experimental procedure has helped patients with refractory hypertension without causing adverse effects on kidney Antiplatelet agents unaffected by proton pump inhibitors Resynchronization slows heart failure progression But study results leave cardiologists wrestling with questions of cost and patient selection Doubling clopidogrel dose makes for safer angioplasty Decrease in heart attack and thrombosis risk outweighs rise in severe bleeding: Canadian study New antiplatelet agent reduces cardiovascular events Pregnancy feasible for heart recipients But better counselling needed on drug risks and long-term maternal survival Ezetimibe-atorvastatin combo proves effective First Previous 84 85 86 87 88 Next Last
